A blog dedicated to investigating events as they occur in Judea and Samaria, in Israel and in the world, and as they relate to global powers and/or to the Israeli government, public figures, etc. It is dedicated to uncovering the truth behind the headlines; and in so doing, it strives to do its part in saving Judea and Samaria, and by extension, Israel and the Jewish People, from utter destruction at the hands of its many external and internal enemies.

Wednesday, October 21, 2009

Vaccinations of KIDS starting next week in New York; meanwhile, in ISRAEL, H1N1 vaccines contain the deadly ADJUVANT MF 59!! .. And other vaccine trivia....

NY Times

October 21, 2009

Schools to Start Offering Swine Flu Shots

Swine flu vaccinations will begin in the city’s public elementary schools next week, officials said Tuesday as they encouraged parents to sign consent forms being sent home with students now.
The city is staggering the schedule to deliver the vaccine as it becomes available. Schools with fewer than 400 students will begin next Wednesday. Schools with more than 600 students will begin Nov. 4, and the rest on Nov. 9. The vaccinations will be given by school nurses and are expected to be available for about eight weeks. Private schools that choose to participate will also receive the vaccine.
Middle and high school students can go to weekend “vaccination events” in November and December, officials said.
Children will get an injection or a nasal spray form of the vaccine, and those younger than 10 years old will need two doses to be fully protected, officials said.

Health Ministry: Pregnant Women to Wait for Swine Shot

Reported: 04:45 AM - Oct/21/09

( The Health Ministry received a large shipment of inoculations against Swine Flu this week – but they will not be used for pregnant women.The doses contain MF59 Adjuvant, a chemical used to increase the immune system's response to the inoculation, but which has an unclear effect on pregnant women.
Since Sunday, Israel has received 250,000 doses of vaccine. Another 100,000 doses, made by pharmaceutical firms Novartis and GSK, will arrive in Israel by the end of the month. All these doses will also include the chemical. The first doses without the chemical will arrive only in November.

.......In some parts of the US, the vaccine is hard to get...

...while Florida and California, where large concentrations of Jews reside,  don't have a shortage, on the contrary...
(as Eric Phelps had predicted: ...New York, Florida, So. California, would be vaccination hubs.... and so it appears to be.)

So. California is vaccinating all its medical staff (voluntary for now), while Florida has excess vaccine quantities.... 

but TEXAS has a shortage!

I will let you interpret this disparity as you wish. I, however, believe it was all planned, and NOT for the benefit of the Jews.

... While European countries will definitely use ADJUVANTED vaccine.

Britain starts giving swine flu shots

Dept. of health hopes to vaccinate 11 million people in coming weeks

updated 4:28 p.m. ET Oct. 20, 2009
LONDON - Britain will start giving swine flu shots to top priority groups, including health care workers and pregnant woman, on Wednesday, the department of health said.
Britain hopes to vaccinate about 11 million people, also including people with underlying conditions such as HIV, cancer and heart disease who are particularly vulnerable, in the next few weeks.
Australia, China and the U.S. have already begun their swine flu vaccination campaigns. Britain initially claimed its vaccination program would start in August.

In recent weeks, swine flu cases have doubled about every two weeks in England. Last week, officials guessed there were about 27,000 new cases.
"Our best line of defense against swine flu is the vaccine," said health secretary Andy Burnham in a statement. He once predicted Britain would have 100,000 new cases a day by the end of August.
Still, it is unclear how many people will actually get the shots. Only about 17 percent of Britain's nurses and doctors regularly get a seasonal flu shot. Since health workers are on the pandemic's front lines, they could easily catch swine flu and spread it widely if they aren't protected.
In the next few weeks, health officials plan to offer swine flu shots to the general public once larger shipments of the vaccine arrive. Britain has ordered enough vaccine from GlaxoSmithKline PLC and Baxter International to cover its entire population, about 60 million people.
Most of Britain's supply is from GlaxoSmithKline, whose one-dose swine flu vaccine contains an adjuvant, a chemical compound used to boost the immune system.
Though adjuvants are commonly used in European flu vaccines, there is limited data on how safe they are in children and pregnant women. Some countries are buying special stocks of swine flu vaccines without adjuvants for groups like pregnant women. None of the swine flu vaccines used in the U.S. have adjuvants( for now, DS)

In Britain, pregnant women will be offered the Glaxo vaccine first, since supplies of Baxter's vaccine — which does not contain an adjuvant and requires two shots — have not yet arrived.
Because it takes about two weeks for people to develop immunity to swine flu after getting a shot, experts say it is crucial people are vaccinated as soon as possible. Flu viruses spread faster in cold temperatures and health officials expect a spike in cases in the winter.
In the vast majority of cases, swine flu is a mild disease from which most people recover without ever needing medical treatment.
© 2009 The Associated Press. All rights reserved. This material ma


U.S. awards $60 million for vaccine boosters

Thu Oct 8, 2009 1:28pm EDT

Full Article Here.

CHICAGO (Reuters) – The U.S. government awarded $60 million to researchers and companies on Thursday to develop vaccine adjuvants — substances designed to boost the immune response and can help stretch short vaccine supplies. “The goal of these awards is to find safe new adjuvants that will boost the effectiveness of vaccines,” Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, which awarded the grants. “Adjuvants can be used not only to enhance the immune response to a vaccine and thereby offer better protection but also to extend the vaccine supply if needed, enabling more people to be vaccinated with fewer doses,” Fauci said in a statement. The five-year contracts went to six researchers, including one from Corixa Corp. of Hamilton, Montana, a unit of Britain-based drugmaker GlaxoSmithKline. Other awards went to researchers at the University of Michigan, the University of California San Diego, the University of Kansas, the University of Washington School of Medicine, and Mount Sinai School of Medicine, New York. Currently, the only vaccine adjuvant approved for use in the United States is an aluminum mixture known as alum, which is not used in flu vaccines because it does a poor job at boosting the immune response. Adjuvants are widely used in flu vaccines in Europe, including vaccines made by Glaxo and Novartis. The World Health Organization promotes the use of adjuvants because they can stretch the short supply of vaccine for H1N1 swine flu vaccine, making more shots available to needy countries. WHO says the global capacity to make influenza vaccines is about 3 billion doses a year — not enough to cover the population of 6.8 billion people.

VACTRUTH Editor’s Note: The WHO, FDA, CDC, NIH, HHS, and proponents of vaccines state that Alum, MF59 and AS03/04 adjuvants already on the market are safe and effective. What is the purpose of replacing something that apparently ‘works’ ?

No comments: